Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
15
Bullish
24
Bearish
0
Neutral
12
Bullish
20
Bearish
0
Neutral
12
Bullish
20
Bearish
0
Neutral
12
Bullish
20
Bearish
0
Neutral
12
Bullish
20
Magenta Lifecare Limited manufactures foam-based household products — principally mattresses and pillows — selling under the ‘Magenta’ brand through a dealer/retailer network, multi-brand outlets and online channels, with a manufacturing plant located in Vadodara, Gujarat and installed capacities of 60,000 mattresses and 70,000 pillows.
Financials for FY2026 show revenue growth to Rs.1,522.55 lakhs (total income) and sales of products and services at Rs.1,442.36 lakhs, representing a material year-on-year revenue increase versus FY2025; however, profitability remains thin with PAT of Rs.11.35 lakhs and low single-digit margins, indicating scale-up stage economics.
Balance sheet and cashflow dynamics reveal working capital strain and funding for growth: trade receivables jumped to Rs.848.28 lakhs, inventories are high at Rs.786.70 lakhs, and borrowings increased significantly, with long-term borrowings rising to Rs.189.65 lakhs and short-term borrowings to Rs.339.48 lakhs, pointing to inventory buildup and dealer stocking.
Differentiation includes product innovation and certifications: Magenta claims India’s first mattresses made from CertiPUR‑US certified foam and has launched herbal (green tea/bamboo charcoal) and pet-bed mattresses, plus adjustable hydraulic bed frames and processed raw foam sales, which broaden addressable markets and support premium positioning.
Corporate governance signals are supportive: the company completed an IPO in June 2024 raising Rs.7 crore, the statutory auditor issued an unmodified opinion for FY2026, and the board approved audited results, providing external assurance as Magenta transitions to a listed, growth-focused operating model.
Consumer Durables
Furniture, Home Furnishing
6 Cr
Moderate Risk
33.6
41.4
1.4
0.5
15.50
6.49
Sales CAGR
Profit CAGR
ROE
ROCE
Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Magenta Lifecare Ltd (MAGENTA) is currently trading at 9.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Magenta Lifecare Limited manufactures foam-based household products — principally mattresses and pillows — selling under the ‘Magenta’ brand through a dealer/retailer network, multi-brand outlets and online channels, with a manufacturing plant located in Vadodara, Gujarat and installed capacities of 60,000 mattresses and 70,000 pillows. Financials for FY2026 show revenue growth to Rs.1,522.55 lakhs (total income) and sales of products and services at Rs.1,442.36 lakhs, representing a material year-on-year revenue increase versus FY2025; however, profitability remains thin with PAT of Rs.11.35 lakhs and low single-digit margins, indicating scale-up stage economics. Balance sheet and cashflow dynamics reveal working capital strain and funding for growth: trade receivables jumped to Rs.848.28 lakhs, inventories are high at Rs.786.70 lakhs, and borrowings increased significantly, with long-term borrowings rising to Rs.189.65 lakhs and short-term borrowings to Rs.339.48 lakhs, pointing to inventory buildup and dealer stocking. Differentiation includes product innovation and certifications: Magenta claims India’s first mattresses made from CertiPUR‑US certified foam and has launched herbal (green tea/bamboo charcoal) and pet-bed mattresses, plus adjustable hydraulic bed frames and processed raw foam sales, which broaden addressable markets and support premium positioning. Corporate governance signals are supportive: the company completed an IPO in June 2024 raising Rs.7 crore, the statutory auditor issued an unmodified opinion for FY2026, and the board approved audited results, providing external assurance as Magenta transitions to a listed, growth-focused operating model.
Over the past 52 weeks, Magenta Lifecare Ltd has traded between a low of ₹6.49 and a high of ₹15.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Magenta Lifecare Ltd has a market capitalization of approximately 6.05. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Magenta Lifecare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.61 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 6.05 Cr, Magenta Lifecare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Magenta Lifecare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Magenta Lifecare Ltd is 33.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
50.90 | 61 Cr | 9.20 | 0.94 | 0.00 | 9.53 | 13.77 | 6.68 | ||
67.50 | 30 Cr | 13.65 | 0.88 | 1.49 | 5.66 | 8.88 | 2.46 | ||
26.27 | 24 Cr | -64.26 | 1.00 | 0.00 | -1.56 | -1.53 | -1.52 | ||
43.00 | 14 Cr | -2.35 | 4.29 | 0.00 | -462.81 | -71.25 | 0.00 | ||
43.26 | 9 Cr | -22.57 | 2.72 | 0.00 | -11.79 | -3.28 | -6.46 | ||
11.00 | 7 Cr | -28.56 | 0.00 | 0.00 | 53.32 | -5.61 | -4.93 | ||
9.50 | 6 Cr | 33.61 | 0.46 | 0.00 | 0.91 | 3.36 | 0.75 | ||
| Median: 7 Co. | — | 43.00 | 14 Cr | -2.35 | 0.94 | 0.00 | 0.91 | -1.53 | 0.00 |
